Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Krishna Institute of Medical Sciences Ltd

Hospital & Healthcare Services

Rating :
N/A

BSE: 543308 | NSE: KIMS

NSE BSE
592.90
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  590.05
  •  601.85
  •  588.00
  •  595.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  540091
  •  3209.20
  •  634.65
  •  350.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23,700.23
  • 71.53
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 25,077.33
  • N/A
  • 11.84

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.82%
  • 0.17%
  • 10.55%
  • FII
  • DII
  • Others
  • 15.85%
  • 31.96%
  • 2.65%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.53
  • 17.35
  • 14.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.64
  • 20.92
  • 4.33

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 47.32
  • 21.08
  • -2.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 45.73

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 8.51

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 24.86

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
7.75
9.93
12
16.23
P/E Ratio
75.94
59.25
49.06
36.26
Revenue
2474
3060
3844
4783
EBITDA
640
817
979
1247
Net Income
310
393
474
645
ROA
9.1
14.6
13.7
15.9
P/Bk Ratio
12.88
10.45
8.6
6.98
ROE
17.73
18.31
18.8
20.51
FCFF
-184.41
-401.45
335.9
583
FCFF Yield
-0.72
-1.58
1.32
2.29

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
777.30
652.50
19.13%
688.40
606.00
13.60%
633.80
575.93
10.05%
605.84
562.16
7.77%
Expenses
559.20
475.20
17.68%
509.00
448.90
13.39%
474.83
412.69
15.06%
458.71
410.98
11.61%
EBITDA
218.10
177.30
23.01%
179.40
157.10
14.19%
158.97
163.23
-2.61%
147.12
151.18
-2.69%
EBIDTM
28.06%
27.17%
26.06%
25.92%
25.08%
28.34%
24.28%
26.89%
Other Income
5.00
2.90
72.41%
4.60
3.10
48.39%
3.81
4.88
-21.93%
3.25
6.45
-49.61%
Interest
19.90
8.90
123.60%
17.90
9.30
92.47%
16.36
5.42
201.85%
12.43
11.52
7.90%
Depreciation
41.00
32.60
25.77%
39.00
32.30
20.74%
46.30
35.43
30.68%
35.38
33.29
6.28%
PBT
162.20
138.70
16.94%
127.10
118.60
7.17%
100.12
127.27
-21.33%
102.57
112.82
-9.09%
Tax
41.50
37.40
10.96%
31.90
31.90
0.00%
28.50
28.60
-0.35%
25.90
30.99
-16.42%
PAT
120.70
101.30
19.15%
95.20
86.70
9.80%
71.62
98.67
-27.41%
76.67
81.83
-6.31%
PATM
15.53%
15.52%
13.83%
14.31%
11.30%
17.13%
12.66%
14.56%
EPS
2.68
2.30
16.52%
2.16
2.02
6.93%
1.64
2.33
-29.61%
1.80
1.90
-5.26%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
2,705.34
2,498.14
2,197.68
1,650.83
1,329.94
1,122.64
567.14
511.82
419.68
351.03
293.76
Net Sales Growth
12.88%
13.67%
33.13%
24.13%
18.47%
97.95%
10.81%
21.95%
19.56%
19.50%
 
Cost Of Goods Sold
557.99
530.29
480.65
355.16
288.93
254.17
138.50
125.83
111.89
99.25
86.64
Gross Profit
2,147.35
1,967.85
1,717.03
1,295.67
1,041.01
868.48
428.64
386.00
307.79
251.78
207.11
GP Margin
79.37%
78.77%
78.13%
78.49%
78.27%
77.36%
75.58%
75.42%
73.34%
71.73%
70.50%
Total Expenditure
2,001.74
1,853.27
1,598.48
1,129.19
954.22
873.16
449.51
402.95
342.42
287.10
232.99
Power & Fuel Cost
-
49.03
43.69
25.83
24.31
24.29
14.18
13.68
12.15
11.99
8.93
% Of Sales
-
1.96%
1.99%
1.56%
1.83%
2.16%
2.50%
2.67%
2.90%
3.42%
3.04%
Employee Cost
-
422.37
346.44
261.91
220.21
198.05
97.97
80.72
69.23
55.65
43.45
% Of Sales
-
16.91%
15.76%
15.87%
16.56%
17.64%
17.27%
15.77%
16.50%
15.85%
14.79%
Manufacturing Exp.
-
715.64
597.29
420.59
366.51
336.25
167.43
149.25
127.52
97.80
79.88
% Of Sales
-
28.65%
27.18%
25.48%
27.56%
29.95%
29.52%
29.16%
30.39%
27.86%
27.19%
General & Admin Exp.
-
102.22
91.97
48.48
38.32
43.64
24.29
24.81
16.13
15.57
11.32
% Of Sales
-
4.09%
4.18%
2.94%
2.88%
3.89%
4.28%
4.85%
3.84%
4.44%
3.85%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
33.72
38.45
17.24
15.94
16.76
7.14
8.65
5.50
6.84
0.00
% Of Sales
-
1.35%
1.75%
1.04%
1.20%
1.49%
1.26%
1.69%
1.31%
1.95%
0.94%
EBITDA
703.59
644.87
599.20
521.64
375.72
249.48
117.63
108.87
77.26
63.93
60.77
EBITDA Margin
26.01%
25.81%
27.27%
31.60%
28.25%
22.22%
20.74%
21.27%
18.41%
18.21%
20.69%
Other Income
16.66
16.16
37.41
20.26
10.16
6.08
2.79
4.57
4.19
7.92
2.94
Interest
66.59
54.57
37.28
21.87
37.33
44.43
32.50
37.04
35.05
31.20
15.07
Depreciation
161.68
146.55
129.26
72.67
69.54
70.61
35.13
35.50
32.27
24.75
20.97
PBT
491.99
459.91
470.08
447.34
279.01
140.53
52.78
40.90
14.13
15.90
27.67
Tax
127.80
123.63
119.09
113.06
73.54
25.45
19.30
12.93
6.93
11.54
9.46
Tax Rate
25.98%
26.88%
24.56%
25.27%
26.36%
18.11%
36.57%
31.61%
49.04%
72.58%
34.19%
PAT
364.19
310.15
336.32
332.69
201.22
119.18
32.93
26.74
6.44
4.35
18.21
PAT before Minority Interest
331.56
336.01
365.81
343.80
205.48
115.07
33.48
27.97
7.20
4.36
18.21
Minority Interest
-32.63
-25.86
-29.49
-11.11
-4.26
4.11
-0.55
-1.23
-0.76
-0.01
0.00
PAT Margin
13.46%
12.42%
15.30%
20.15%
15.13%
10.62%
5.81%
5.22%
1.53%
1.24%
6.20%
PAT Growth
-1.17%
-7.78%
1.09%
65.34%
68.84%
261.92%
23.15%
315.22%
48.05%
-76.11%
 
EPS
9.10
7.75
8.41
8.32
5.03
2.98
0.82
0.67
0.16
0.11
0.46

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
1,828.36
1,669.54
1,387.31
863.73
598.13
Share Capital
80.03
80.03
80.03
77.59
74.49
Total Reserves
1,748.33
1,589.51
1,307.28
786.14
523.33
Non-Current Liabilities
1,274.57
666.67
278.49
278.70
364.23
Secured Loans
922.74
492.54
137.66
184.60
268.72
Unsecured Loans
4.90
4.90
0.00
0.00
0.00
Long Term Provisions
27.42
23.63
17.05
16.06
13.71
Current Liabilities
452.29
296.47
215.00
278.32
218.81
Trade Payables
197.15
174.25
129.53
131.87
123.43
Other Current Liabilities
145.06
88.60
73.20
72.00
77.92
Short Term Borrowings
91.47
19.55
1.76
55.27
10.11
Short Term Provisions
18.61
14.06
10.51
19.19
7.35
Total Liabilities
3,820.10
2,901.10
1,904.13
1,433.21
1,194.48
Net Block
2,433.91
1,766.32
1,005.21
931.08
915.98
Gross Block
3,019.09
2,197.96
1,329.42
1,190.02
1,106.30
Accumulated Depreciation
585.18
431.64
324.21
258.94
190.33
Non Current Assets
3,272.66
2,423.47
1,510.74
982.02
974.64
Capital Work in Progress
600.09
476.93
20.76
9.24
2.23
Non Current Investment
74.43
0.00
332.48
0.00
0.00
Long Term Loans & Adv.
157.86
171.88
148.73
34.79
55.02
Other Non Current Assets
6.37
8.33
3.56
6.91
1.42
Current Assets
547.44
477.64
393.40
451.19
219.83
Current Investments
82.97
67.89
0.00
0.00
0.00
Inventories
49.44
42.87
36.43
24.09
30.38
Sundry Debtors
294.40
252.65
128.64
109.82
132.27
Cash & Bank
49.01
66.37
190.06
284.44
45.73
Other Current Assets
71.61
5.03
5.02
12.88
11.46
Short Term Loans & Adv.
63.45
42.83
33.24
19.97
10.10
Net Current Assets
95.15
181.17
178.39
172.87
1.02
Total Assets
3,820.10
2,901.11
1,904.14
1,433.21
1,194.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
521.09
432.09
324.02
355.97
201.50
PBT
459.64
484.91
456.85
279.01
140.53
Adjustment
186.17
113.70
68.54
100.56
114.53
Changes in Working Capital
15.43
-69.28
-74.47
14.15
0.12
Cash after chg. in Working capital
661.24
529.32
450.92
393.72
255.17
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-140.15
-97.23
-126.90
-37.74
-53.67
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-752.56
-546.89
-411.52
-354.18
-124.71
Net Fixed Assets
-395.18
-64.99
-57.47
-68.27
Net Investments
-236.25
-284.03
-328.79
-35.26
Others
-121.13
-197.87
-25.26
-250.65
Cash from Financing Activity
216.75
19.64
61.00
9.82
-44.34
Net Cash Inflow / Outflow
-14.72
-95.17
-26.50
11.62
32.45
Opening Cash & Equivalents
61.61
25.63
52.13
40.51
8.06
Closing Cash & Equivalent
46.89
61.61
25.63
52.13
40.51

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
45.69
41.72
173.35
111.32
80.25
ROA
10.00%
15.23%
20.60%
15.64%
9.97%
ROE
19.21%
23.93%
30.55%
28.12%
20.22%
ROCE
20.26%
27.84%
35.69%
30.82%
21.17%
Fixed Asset Turnover
0.96
1.25
1.31
1.16
1.07
Receivable days
39.96
31.66
26.36
33.22
41.54
Inventory Days
6.74
6.58
6.69
7.47
9.30
Payable days
127.82
115.35
134.33
161.26
46.79
Cash Conversion Cycle
-81.11
-77.10
-101.27
-120.57
4.06
Total Debt/Equity
0.57
0.32
0.12
0.31
0.54
Interest Cover
9.42
14.01
21.89
8.47
4.16

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Krishna Institute of Medical acquires additional 3% stake in M/s. Arunodaya Hospitals
    6th Dec 2024, 10:10 AM

    Consequently, the Company now holds 70.66% of the total paid-up equity share capital of M/s. Arunodaya Hospitals

    Read More
  • Krishna Institute of Medical Sciences inks pact with Insignia Healthcare
    11th Nov 2024, 10:12 AM

    The Super Specialty Hospital will be under the exclusive supervision and control of KIMS, and shall be branded as ‘KIMS-SIKHARA’

    Read More
  • Krishna Inst.Medi - Quarterly Results
    9th Nov 2024, 16:01 PM

    Read More
  • Krishna Institute of Medical to develop new medical facilities in Kerala
    6th Nov 2024, 18:01 PM

    KIMS Hospitals, currently has presence in the 5 states of Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka with over 16 hospitals and 5000 plus beds

    Read More
  • Krishna Institute of Medical makes further investment in M/s. Sarvejana Healthcare
    31st Oct 2024, 10:11 AM

    Consequently, the Company now holds 68.59% of the total paid-up equity share capital of M/s. Sarvejana Healthcare

    Read More
  • Krishna Institute of Medical acquires additional stake in Sarvejana Healthcare
    22nd Oct 2024, 15:57 PM

    The company now holds 66.35% of the total paid-up equity share capital of Sarvejana Healthcare

    Read More
  • Krishna Institute inks MoU with Wipro GE Healthcare
    18th Oct 2024, 16:42 PM

    The MoU is to procure medical technology and services of Upto Rs 700 crore

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.